Interferon(alpha) Therapy
"Hepatitis C-Associated Osteosclerosis (HCAO): Effects of Treatment by Interferon(alpha) (IFN{ LEFTCUR
Published in Hepatitis Weekly, December 21st, 1998
According to an abstract submitted by the authors to the 2nd Joint Meeting of the American Society for Bone and Mineral Research and the International Bone and Mineral Society, held December 1-6, 1998, in San Francisco, California, "Hepatitis C has been recognized as a secondary cause of osteosclerosis. There have been some reports of the use of antiresorptive therapies in this condition with mixed results. We describe here the effects of by IFN(alpha) in a patient with HCAO. A 44 year old white male was referred for suffering from bone pain in the lower limbs for the past 6 months. He had a history of chronic hepatitis since age 18. He has been an intravenous drug user in the past...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1998-12-21)
More Articles from Hepatitis Weekly
- Conference Coverage (AASLD)
Angiogenesis Predictive of HCC in Chronic HCV - Animal Models
WHV Activity Shows Ganciclovir May Be Useful Against HBV - Carcinoma
Predictors of Survival in HCV+ HCC Reported - Conference Coverage (AASLD)
"Cocktail" Approach May be Useful for HCV - Epidemiology
Large Decrease in Hepatitis Seen in Young Adults in Okinawa - Etiology
Hepatitis G Common in Those with Genetic Hemochromatosis - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
